- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00394849
Effect of Tonsillar Pillar Closure on Postoperative Pain and Bleeding Risk After Tonsillectomy
November 3, 2017 updated by: Bruce Matt, Indiana University School of Medicine
The purpose of this study is to determine if closing the tonsil fossa after tonsillectomy leads to less pain and bleeding risk than leaving it open to heal by secondary intention.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
After induction of appropriate general anesthesia, a tonsillectomy was performed and control of bleeding was achieved as is routine for the individual Otolaryngologist performing the procedure.
Next the surgeon used 3-0 chromic (absorbable) sutures on tapered needles to close one tonsillar fossa but leave the tonsillar fossa on the other side open.
The side chosen was determined by a computer generated schedule.
Routine postoperative care was given.
Study Type
Interventional
Enrollment (Actual)
763
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Indiana
-
Indianapolis, Indiana, United States, 46202
- Riley Childrens' Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Any patient for whom tonsillectomy is recommended for recurrent pharyngitis, obstructive sleep disorder, snoring, halitosis, feeding difficulty associated with adenotonsillar hypertrophy, and who in the investigator's opinion, is capable of providing reliable responses to post-operative follow-up questions as defined in this protocol.
Exclusion Criteria:
- Any patient for whom tonsillectomy is recommended for suspected malignancy or active peritonsillar abscess
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: suture one tonsillar fossa
Intervention: one tonsillar fossa was sutured.
One side was not sutured.
Pain was compared side to side.
|
one tonsillar fossa was sutured.
One side was not sutured.
Pain was compared side to side.
|
|
No Intervention: One side not sutured
Intervention: one tonsillar fossa was sutured.
One side was not sutured.
Pain was compared side to side.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
which side was more painful on or about postoperative day 14
Time Frame: 14 days
|
determined which side was more painful on or about postoperative day 14 by asking patient and/or care giver
|
14 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Additional information was obtained about details if postoperative bleeding occurred, including which side bled and details of the event
Time Frame: 40 days
|
Additional information was obtained about details if postoperative bleeding occurred.
Specifically, if postoperative bleeding occurred, we sought to obtain as many details as possible about the events.
Items such as when the postoperative bleeding occurred, what was done about it, where the subject was treated, and what the outcome was ( was the bleeding controlled, did the subject have other complications or concerns, etc. were elicited
|
40 days
|
|
any other adverse events (complications)
Time Frame: 40 days
|
determined if other complications occurred
|
40 days
|
|
which side was more painful on or about postoperative day 21
Time Frame: 21 days
|
determined which side was more painful on or about postoperative day 21 by asking patient and/or care giver
|
21 days
|
|
overall assessment at the postoperative clinic visit (on or about day 28)
Time Frame: 28 days
|
determined overall assessment at the postoperative clinic visit (on or about day 28) by asking patient and/or care giver
|
28 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Bruce H. Matt, MD, MS, Indiana University School of Medicine
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2000
Primary Completion (Actual)
March 1, 2004
Study Completion (Actual)
March 1, 2004
Study Registration Dates
First Submitted
October 30, 2006
First Submitted That Met QC Criteria
October 30, 2006
First Posted (Estimate)
November 1, 2006
Study Record Updates
Last Update Posted (Actual)
November 7, 2017
Last Update Submitted That Met QC Criteria
November 3, 2017
Last Verified
November 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0006-26
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.